Supply Chain Resilience and Regionalization
Following years of geopolitical shifts, 2026 has seen a major push toward Regionalization in generic drug manufacturing.
Distributed Manufacturing: Companies are moving away from centralized global hubs to "distributed manufacturing" models. Sponsors now prioritize Contract Development and Manufacturing Organizations (CDMOs) with multi-regional footprints to avoid supply chain disruptions caused by port congestion or trade disputes.
Sustainability Mandates: 2026 regulations now tie market approval to "Green GMP" (Good Manufacturing Practices), requiring companies to disclose water usage, energy optimization, and chemical waste management metrics.
1 visualização